Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleSupplement

Evaluation of Prostate Cancer Bone Metastases with 18F-NaF and 18F-Fluorocholine PET/CT

Mohsen Beheshti, Alireza Rezaee, Hans Geinitz, Wolfgang Loidl, Christian Pirich and Werner Langsteger
Journal of Nuclear Medicine October 2016, 57 (Supplement 3) 55S-60S; DOI: https://doi.org/10.2967/jnumed.115.169730
Mohsen Beheshti
1Department of Nuclear Medicine and Endocrinology, PET–CT Center Linz, St. Vincent’s Hospital, Linz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alireza Rezaee
1Department of Nuclear Medicine and Endocrinology, PET–CT Center Linz, St. Vincent’s Hospital, Linz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans Geinitz
2Department of Radiation Oncology, St. Vincent’s Hospital, Linz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang Loidl
3Department of Urology, St. Vincent’s Hospital, Linz, Austria; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Pirich
4Department of Nuclear Medicine, Paracelsus Private Medical University, Salzburg, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Werner Langsteger
1Department of Nuclear Medicine and Endocrinology, PET–CT Center Linz, St. Vincent’s Hospital, Linz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 57 no. Supplement 3 55S-60S
DOI 
https://doi.org/10.2967/jnumed.115.169730
PubMed 
27694173

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication March 14, 2016
  • Accepted for publication May 1, 2016
  • Published online October 2, 2016.

Copyright & Usage 
© 2016 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Mohsen Beheshti1,
  2. Alireza Rezaee1,
  3. Hans Geinitz2,
  4. Wolfgang Loidl3,
  5. Christian Pirich4 and
  6. Werner Langsteger1
  1. 1Department of Nuclear Medicine and Endocrinology, PET–CT Center Linz, St. Vincent’s Hospital, Linz, Austria
  2. 2Department of Radiation Oncology, St. Vincent’s Hospital, Linz, Austria
  3. 3Department of Urology, St. Vincent’s Hospital, Linz, Austria; and
  4. 4Department of Nuclear Medicine, Paracelsus Private Medical University, Salzburg, Austria
  1. For correspondence or reprints contact: Mohsen Beheshti, Department of Nuclear Medicine and Endocrinology, PET–CT Center Linz, St. Vincent’s Hospital, Seilerstaette 4, A-4020 Linz, Austria. E-mail: mohsen.beheshti{at}bhs.at
View Full Text

Statistics from Altmetric.com

Cited By...

  • 49 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
    Matthew R. Smith, Fred Saad, Simon Chowdhury, Stéphane Oudard, Boris A. Hadaschik, Julie N. Graff, David Olmos, Paul N. Mainwaring, Ji Youl Lee, Hiroji Uemura, Angela Lopez-Gitlitz, Géralyn C. Trudel, Byron M. Espina, Youyi Shu, Youn C. Park, Wayne R. Rackoff, Margaret K. Yu, Eric J. Small
    New England Journal of Medicine 2018 378 15
  • Hormonal Therapy for Prostate Cancer
    Kunal Desai, Jeffrey M McManus, Nima Sharifi
    Endocrine Reviews 2021 42 3
  • The 68Ga/177Lu theragnostic concept in PSMA targeting of castration-resistant prostate cancer: correlation of SUVmax values and absorbed dose estimates
    Lorenza Scarpa, Sabine Buxbaum, Dorota Kendler, Katharina Fink, Jasmin Bektic, Leonhard Gruber, Clemens Decristoforo, Christian Uprimny, Peter Lukas, Wolfgang Horninger, Irene Virgolini
    European Journal of Nuclear Medicine and Molecular Imaging 2017 44 5
  • Quantitative bone SPECT/CT: high specificity for identification of prostate cancer bone metastases
    Flavian Tabotta, Mario Jreige, Niklaus Schaefer, Fabio Becce, John O. Prior, Marie Nicod Lalonde
    BMC Musculoskeletal Disorders 2019 20 1
  • Quantitative Assessment of Early [18F]Sodium Fluoride Positron Emission Tomography/Computed Tomography Response to Treatment in Men With Metastatic Prostate Cancer to Bone
    Stephanie A. Harmon, Timothy Perk, Christie Lin, Jens Eickhoff, Peter L. Choyke, William L. Dahut, Andrea B. Apolo, John L. Humm, Steven M. Larson, Michael J. Morris, Glenn Liu, Robert Jeraj
    Journal of Clinical Oncology 2017 35 24
  • Imaging for Metastasis in Prostate Cancer: A Review of the Literature
    Anthony Turpin, Edwina Girard, Clio Baillet, David Pasquier, Jonathan Olivier, Arnauld Villers, Philippe Puech, Nicolas Penel
    Frontiers in Oncology 2020 10
  • ACR Appropriateness Criteria® Management of Vertebral Compression Fractures
    Lubdha M. Shah, Jack W. Jennings, Claudia F.E. Kirsch, Eric J. Hohenwalter, Francesca D. Beaman, R. Carter Cassidy, Michele M. Johnson, A. Tuba Kendi, Simon Shek-Man Lo, Charles Reitman, Arjun Sahgal, Matthew J. Scheidt, Kristofer Schramm, Daniel E. Wessell, Mark J. Kransdorf, Jonathan M. Lorenz, Julie Bykowski
    Journal of the American College of Radiology 2018 15 11
  • Current Imaging Techniques for and Imaging Spectrum of Prostate Cancer Recurrence and Metastasis: A Pictorial Review
    Takashi Tanaka, Ming Yang, Adam T. Froemming, Alan H. Bryce, Ryota Inai, Susumu Kanazawa, Akira Kawashima
    RadioGraphics 2020 40 3
  • Whole-Body MRI with Diffusion-Weighted Imaging in Bone Metastases: A Narrative Review
    Alessandro Stecco, Alessandra Trisoglio, Eleonora Soligo, Sara Berardo, Lidiia Sukhovei, Alessandro Carriero
    Diagnostics 2018 8 3
  • Comparison of [68Ga]Ga-PSMA-11 PET/CT with [18F]NaF PET/CT in the evaluation of bone metastases in metastatic prostate cancer patients prior to radionuclide therapy
    Christian Uprimny, Anna Svirydenka, Josef Fritz, Alexander Stephan Kroiss, Bernhard Nilica, Clemens Decristoforo, Roland Haubner, Elisabeth von Guggenberg, Sabine Buxbaum, Wolfgang Horninger, Irene Johanna Virgolini
    European Journal of Nuclear Medicine and Molecular Imaging 2018 45 11

Article usage

Article usage: October 2016 to April 2025

AbstractFullPdf
Oct 201681336148
Nov 20163462550
Dec 20161711423
Jan 20171891734
Feb 20171441424
Mar 2017991110
Apr 2017583432
May 2017722635
Jun 2017732529
Jul 2017553932
Aug 2017593630
Sep 2017273026
Oct 2017325039
Nov 2017233743
Dec 2017273838
Jan 2018234131
Feb 2018373217
Mar 2018383118
Apr 2018253628
May 2018263327
Jun 2018312919
Jul 2018182016
Aug 2018171945
Sep 201863024
Oct 2018143015
Nov 2018241918
Dec 2018111816
Jan 2019252434
Feb 2019132823
Mar 2019172543
Apr 2019102319
May 2019131626
Jun 201971213
Jul 2019101419
Aug 201991216
Sep 20197823
Oct 2019152220
Nov 201915824
Dec 201961311
Jan 2020191113
Feb 2020151114
Mar 2020171725
Apr 2020151725
May 202015610
Jun 2020101215
Jul 2020742
Aug 202012104
Sep 202072321
Oct 2020211917
Nov 202016918
Dec 2020102020
Jan 202112117
Feb 202162321
Mar 202153632
Apr 202132822
May 202153731
Jun 20211169
Jul 202162118
Aug 202122420
Sep 202112718
Oct 202142320
Nov 202122624
Dec 202162822
Jan 202253114
Feb 20223227
Mar 202252614
Apr 202242627
May 202223017
Jun 202202317
Jul 202244415
Aug 202232912
Sep 202232516
Oct 202222815
Nov 20221268
Dec 202233517
Jan 202364424
Feb 20234189
Mar 202396725
Apr 202352210
May 202361519
Jun 202362520
Jul 202352213
Aug 202331311
Sep 202331312
Oct 202331410
Nov 20230219
Dec 20236278
Jan 202423419
Feb 2024132822
Mar 2024103632
Apr 202466346
May 202425615
Jun 202476323
Jul 202424612
Aug 202474421
Sep 202434418
Oct 202447523
Nov 202437918
Dec 20242829
Jan 202577922
Feb 2025115015
Mar 2025215331
Apr 2025916730
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 57 (Supplement 3)
Journal of Nuclear Medicine
Vol. 57, Issue Supplement 3
October 1, 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of Prostate Cancer Bone Metastases with 18F-NaF and 18F-Fluorocholine PET/CT
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Evaluation of Prostate Cancer Bone Metastases with 18F-NaF and 18F-Fluorocholine PET/CT
Mohsen Beheshti, Alireza Rezaee, Hans Geinitz, Wolfgang Loidl, Christian Pirich, Werner Langsteger
Journal of Nuclear Medicine Oct 2016, 57 (Supplement 3) 55S-60S; DOI: 10.2967/jnumed.115.169730

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Evaluation of Prostate Cancer Bone Metastases with 18F-NaF and 18F-Fluorocholine PET/CT
Mohsen Beheshti, Alireza Rezaee, Hans Geinitz, Wolfgang Loidl, Christian Pirich, Werner Langsteger
Journal of Nuclear Medicine Oct 2016, 57 (Supplement 3) 55S-60S; DOI: 10.2967/jnumed.115.169730
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • 18F-FLUOROCHOLINE PET/CT
    • 18F-FLUOROCHOLINE PET/MRI
    • 18F-NAF PET/CT
    • COMPARISON OF 18F-NAF WITH 18F-FLUOROCHOLINE PET/CT
    • CONCLUSION
    • DISCLOSURE
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Radiotheranostics in Prostate Cancer: Introduction and Overview
  • Google Scholar

More in this TOC Section

  • The Role of Total-Body PET in Drug Development and Evaluation: Status and Outlook
  • Melanin-Targeting Radiotracers and Their Preclinical, Translational, and Clinical Status: From Past to Future
  • Advancing Global Nuclear Medicine: The Role and Future Contributions of China
Show more Supplement

Similar Articles

Keywords

  • prostate cancer
  • bone metastasis
  • 18F-NaF PET/CT
  • 18F-choline PET/CT
SNMMI

© 2025 SNMMI

Powered by HighWire